rare disease data center
Rare Disease Data Center vs Manual Registry: Investors Beware
Rare Disease Data Center vs Manual Registry: Investors Beware The rare disease data center cuts drug development time by nearly half, dropping the window from 15 years to 8 years. Compared with manual registries, it delivers faster, more accurate data integration, lowering risk for investors. This speed stems from real-time